Evidence map›Paper›PMID 33029513›Full record

ArticleBioMed research international2020

Alkaloids from

Lawrence Sheringham Borquaye, Edward Ntim Gasu, Gilbert Boadu Ampomah, Lois Kwane Kyei, Margaret Amerley Amarh, Caleb Nketia Mensah, Daniel Nartey, Michael Commodore, Abigail Kusiwaa Adomako, Philipina Acheampong and 3 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Heliyon · 2024
    Article
  5. The use ofClinical case reports · 2024
    Article
  6. Article
  7. Marine-Derived Furanones Targeting Quorum-Sensing Receptors inBioinformatics and biology insights · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Inhibition of the main protease of SARS-CoV-2 (MComputational and structural biotechnology journal · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Lawrence Sheringham BorquayeDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.ORCID https://orcid.org/0000-0002-5037-0777
Edward Ntim GasuDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.ORCID https://orcid.org/0000-0002-1752-0948
Gilbert Boadu AmpomahDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.ORCID https://orcid.org/0000-0003-1082-0291
Lois Kwane KyeiCentral Laboratory, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Margaret Amerley AmarhDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Caleb Nketia MensahDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Daniel NarteyDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Michael CommodoreDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Abigail Kusiwaa AdomakoDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Philipina AcheampongDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Jehoshaphat Oppong MensahDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
David Batsa MormorDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Caleb Impraim AboagyeDepartment of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Kwame Nkrumah University of Science and Technology · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ongoing global pandemic caused by the human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected millions of people and claimed hundreds of thousands of lives. The absence of approved therapeutics to combat this disease threatens the health of all persons on earth and could cause catastrophic damage to society. New drugs are therefore urgently required to bring relief to people everywhere. In addition to repurposing existing drugs, natural products provide an interesting alternative due to their widespread use in all cultures of the world. In this study, alkaloids from

Indexed as

AlkaloidsAntiviral AgentsBetacoronavirusComputer SimulationCoronavirus 3C ProteasesCoronavirus InfectionsCoronavirus RNA-Dependent RNA PolymeraseCOVID-19CryptolepisCysteine EndopeptidasesDrug Evaluation, PreclinicalHumansIndole AlkaloidsMolecular Docking SimulationMolecular Dynamics SimulationPandemicsAlkaloidsAntiviral AgentsCoronavirus 3C ProteasesCoronavirus RNA-Dependent RNA PolymerasecryptospirolepineCysteine EndopeptidasesIndole AlkaloidsNSP12 protein, SARS-CoV-2QuinolinesRNA-Dependent RNA PolymeraseViral Nonstructural ProteinsViral Proteins

Identifiers

PMID33029513
PMCPMC7512045
OpenAlexW3088854155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.